We demonstrated for the first time that Corynoline could suppress H2O2‐induced osteoblast damage by activating the Nrf2/HO‐1 pathway, proving Corynoline as a suitable therapeutic option for osteoporosis. Here, HMOX1 is linked to osteoporosis.